"Research and development"

View all stories
article thumbnail

Merck scientists probe how our bodies' bugs impact immunity and disease

Our researchers are pioneering new ways to research and understand the biology of new diseases by looking inside the human gut

article thumbnail

Businesses have a role to play in building vaccine trust. Here's why

Employers are trusted messengers of credible information on vaccines

article thumbnail

Merck publishes 2019/2020 corporate responsibility report

Letter from our chairman and CEO, Ken Frazier

article thumbnail

Vaccines aren’t virtual

The importance of childhood well visits to prevent certain infectious diseases during the pandemic - by Nick Kartsonis, SVP clinical research, vaccines and infectious disease

article thumbnail

Our new London Discovery Research Center site

The $1.32 billion, 220,000-square-foot research facility will be located in London’s “Knowledge Quarter”

article thumbnail

No patient left behind in our clinical trials

We’re here for patients when they need us most

article thumbnail

If you build it (in 3D), they will come

Innovating with the power of 3D printing

article thumbnail

Merck tackles epidemics and pandemics: an illustrated history

article thumbnail

Why Merck is well-positioned to tackle the COVID-19 pandemic

with Daria Hazuda, VP, infectious disease discovery and chief science officer

article thumbnail

Confronting a new era in immunization

By John Markels, Ph.D., president, Merck Vaccines

article thumbnail

Merck announces three significant scientific efforts in the fight against COVID-19

article thumbnail

No patient left behind: making the impossible possible for clinical trials during adversity

With Andy Lee, head of global clinical trial operations

article thumbnail

Clinical trials bring our medicines and vaccines to life

We appreciate all who have contributed to our clinical research

article thumbnail

Taking prostate cancer research forward

article thumbnail

Merck joins the World Cancer Day movement to push for progress

Cancer is one of the most significant health challenges of our time – cutting lives too short for far too many people.

article thumbnail

Lung cancer

Lung cancer is the most commonly diagnosed cancer worldwide.

article thumbnail

Merck joins South San Francisco biotech community with innovative research site and hunger for collaboration

article thumbnail

Working together to create a sustainable market for antibiotics

It’s time to take action to slow the advance of AMR – but we cannot do it alone. By Jenelle Krishnamoorthy, associate vice president, Global Policy, Communications & Population Health

article thumbnail

Meet a scientist who helps translate inventions into vaccines to protect public health: Beth-Ann Coller

article thumbnail

Dr. Maurice Hilleman: "The father of modern vaccines"

article thumbnail

Meet two scientists whose goals are to help end the HIV epidemic

article thumbnail

How we are building a strong foundation in pancreatic cancer research

Dr. Peter Kang, executive director, clinical research, Merck Research Laboratories, shares his perspective on why there are reasons for hope.

article thumbnail

Let's talk about kidney cancer